Antioxidant treatment for impaired hypoxic ventilatory responses in experimental diabetes in the rat

In conclusion, mangiferin holds a therapeutic promise in breaking the mesh of chronic tissue hypoxia, inflammation, and oxidative stress in diabetes by enhancing ventilation.
Source: Respiratory Physiology and Neurobiology - Category: Respiratory Medicine Source Type: research